Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Week in Review

Week in Review: Haohai Bio Enters $527 Million Deal for Dermatology Products
Week in Review: OrbiMed Raises $800 Million for its Fourth Asia Fund
Week in Review: China Life Science Scores over $1 Billion in Week's Deals
Week in Review: Yuanxin Raises $465 Million for Online Healthcare Company Miaoshou Doctor
Week in Review: Suzhou's Adagene Raises $140 Million in US IPO to Develop Oncology Drugs
Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021